# About the Study

HeartBEAT is a Phase II randomized controlled trial, 4 center trial that evaluates the effects of supplemental nocturnal oxygen or Positive Airway Pressure (PAP) therapy, compared to optimal medical preventive therapy, over a 3 month intervention period in patients with cardiovascular disease (CVD) or CVD risk factors and moderate to severe obstructive sleep apnea (apnea hypopnea index 15 to 50). The studyâ€™s primary outcome is 24 hour blood pressure profile.

## Citation

When citing this dataset please use:

> Redline, S., et al. "HeartBEAT Study." National Sleep Research Resource. Web. http://sleepdata.org/datasets/heartbeat.
